• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Cyclical·EWLU
Share

Merion, Inc. Stocks

$ 0Last Updated 31.07.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 6229

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Merion, Inc. operates as a provider of health and nutritional supplements, alongside personal care products, serving markets in both the United States and the People's Republic of China. Its diverse product lineup includes "Noir Naturel," a gentle hair treatment designed to cover grey from the initial application; the "Viwooba" series (1-3), natural aphrodisiac supplements formulated for men; "Lady-S," a dietary aid created to assist women with weight loss; "Gold King," a nutritional supplement offering antioxidant benefits and supporting liver health; "New Power," specifically developed to promote cardiac well-being; "Taibao," a supplement aimed at boosting physical performance and energy metabolism; and "ReMage Power," a nutritional product that aids anti-aging through Nicotinamide adenine dinucleotide (NAD+) support while also enhancing cellular energy and metabolism. The company distributes its products directly to consumers through its website, merionus.com, and also supplies wholesale distributors via phone and other electronic communication methods. Originally founded in 2007 as E-World USA Holding, Inc., the company adopted the name Merion, Inc. in June 2017. Its main office is located in West Covina, California.

Company Valuation

Greatly undervalued
7/7

From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

02.08.2026 02:30

An explosion occurred near a restaurant in central Moscow; there are fatalities

01.08.2026 16:01

Small caps last week: Cathie Wood’s Scribe bet, deals to acquire Forte Bio and CBIZ

01.08.2026 13:01

Apple's Short-Lived Triumph, Non-Banks Battle for Colombia, and a Dinosaur Worth Millions of Dollars

01.08.2026 04:17

Not a White Knight: How the “Savior” of “AI-Nostradamus” Makes Money by Sensing Trouble

01.08.2026 03:08

Trump Ordered New Strikes Against Iran — WSJ

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026